Department of Autoimmune Diseases, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain.
Department of Nephrology and Renal Transplantation, Hospital Clínic, Barcelona, Spain.
J Nephrol. 2021 Dec;34(6):1897-1905. doi: 10.1007/s40620-021-01007-z. Epub 2021 Mar 15.
Lupus nephritis (LN) is a major complication in patients with systemic lupus erythematosus (SLE). Tubulointerstitial injury is an inflammatory process that, if not attenuated, can promote renal damage. Despite this, the current 2003 ISN/RPS "glomerulocentric" classification does not include a score for tubulointerstitial injury. We sought to establish predictors for tubulointerstitial injury and to determine their influence on renal outcomes.
This is a retrospective study of a cohort of 166 patients with biopsy-proven LN diagnosed in a Spanish referral center, with a median follow-up of 86 months. Chronic tubulointerstitial lesions were defined as interstitial fibrosis and tubular atrophy (IF/TA), whereas tubulointerstitial inflammation (TII) was defined as an acute interstitial lesion. Activity (0-24) and chronicity (0-12) indices were assigned.
Composite outcome, defined as advanced CKD or development of kidney failure.
The prevalence of tubulointerstitial lesions was 69.3%. Eighty-one of the biopsies had features of tubulointerstitial inflammation and only 6 of these 81 (7%) patients had moderate/severe tubulointerstitial inflammation. The incidence of interstitial fibrosis and tubular atrophy was 56.6%. Renal survival was shorter in patients with moderate/severe as compared with absent/mild interstitial fibrosis and tubular atrophy (median: 15-19 years, p = 0.009). In the Cox regression model, the grade of interstitial fibrosis and tubular atrophy was independently associated with shorter renal survival (hazard ratio: 3.9, 95% CI 1.4-10.5; p = 0.008) after adjusting for degree of IF/TA and hypertension or diabetes.
The extent of tubulointerstitial inflammation emerged as an independent predictor of renal survival after adjusting for the grade of interstitial fibrosis and tubular atrophy and co-morbid conditions including hypertension or diabetes. Regarding disease duration at the time of renal biopsy, no significant association was found between the interstitial fibrosis and tubular atrophy groups. The results reported herein need to be validated in future studies to include also groups of patients who usually have a worse prognosis. Consensus on histological classification is needed to aid in defining prognosis.
狼疮肾炎(LN)是系统性红斑狼疮(SLE)患者的主要并发症。肾小管间质性损伤是一种炎症过程,如果不加以抑制,可能会导致肾脏损伤。尽管如此,目前 2003 年 ISN/RPS 的“肾小球中心”分类并不包括肾小管间质性损伤的评分。我们试图确定肾小管间质性损伤的预测因素,并确定其对肾脏结局的影响。
这是一项回顾性研究,纳入了在西班牙转诊中心诊断为 LN 的 166 例经活检证实的患者队列,中位随访时间为 86 个月。慢性肾小管间质性病变定义为间质纤维化和肾小管萎缩(IF/TA),而肾小管间质性炎症(TII)定义为急性间质性病变。给予活动(0-24)和慢性(0-12)指数评分。
定义为进展性慢性肾脏病或发生肾衰竭的复合结局。
肾小管间质性病变的患病率为 69.3%。81 例活检标本有肾小管间质性炎症特征,而在这 81 例患者中仅有 6 例(7%)有中重度肾小管间质性炎症。间质纤维化和肾小管萎缩的发生率为 56.6%。与无或轻度间质纤维化和肾小管萎缩相比,中重度间质纤维化和肾小管萎缩患者的肾脏生存率更短(中位:15-19 年,p=0.009)。在 Cox 回归模型中,调整 IF/TA 程度和高血压或糖尿病后,肾小管间质性纤维化和萎缩程度与肾脏生存率缩短独立相关(危险比:3.9,95%CI 1.4-10.5;p=0.008)。
在调整间质纤维化和肾小管萎缩程度以及高血压或糖尿病等合并症后,肾小管间质性炎症的程度成为肾脏生存率的独立预测因素。关于肾脏活检时的疾病持续时间,在间质纤维化和肾小管萎缩组之间未发现显著相关性。本报告的结果需要在未来的研究中进行验证,包括预后通常较差的患者群体。需要就组织学分类达成共识,以帮助确定预后。